treatment guidelines

Research in Review

Ovarian Cancer Associated With Out-of-Pocket Financial Burden

06/07/2017

JCP Editors

Patients receiving treatment for ovarian cancer experienced a significant out-of-pocket financial burden, due largely to cost disparities across treatment types and a lack of definitive treatment options, according...

...

06/07/2017

Journal of Clinical Pathways

Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations

06/04/2017

JCP Editors

Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...

...

06/04/2017

Journal of Clinical Pathways

Research in Review

Working Group Considers Appropriate Endpoints for Metastatic Breast Cancer Trial

06/04/2017

JCP Editors

A working group composed of breast cancer researchers have determined a list of appropriate endpoints for clinical trials of patients with metastatic breast cancer, according to data presented at the 2017 ASCO Annual...

A...

06/04/2017

Journal of Clinical Pathways

Real-World Data Shows Metastatic Bladder Cancer Survival Worse Than in Clinical Trials

05/31/2017

JCP Editors

Few patients with metastatic urothelial carcinoma of the bladder are surviving as long in the real-world as those in clinical trials, according to new research. Current overall survival projections for patients with...

Few...

05/31/2017

Journal of Clinical Pathways

Research in Review

Young Patients With Colorectal Cancer May Benefit From More Treatment Options

05/25/2017

JCP Editors

Patients aged 45 years or younger with colorectal cancer may have better treatment options available to them because of more mutations in their tumors than older patients, according to research that will be presented...

...

05/25/2017

Journal of Clinical Pathways

Research in Review

Blended Cognitive Behavior Therapy Decreases Fear of Cancer Recurrence

05/24/2017

JCP Editors

Survivors of cancer with fear of cancer recurrence may be effectively treated with a blended therapeutic approach involving face-to-face and online sessions, according to a study published in the Journal of Clinical...

...

05/24/2017

Journal of Clinical Pathways

Guideline-Recommended Therapy Underused in Rare Form of Bladder Cancer

05/16/2017

JCP Editors

Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...

...

05/16/2017

Journal of Clinical Pathways

Research in Review

Biomarker-Driven Treatment Does Not Improve NSCLC Outcomes

05/15/2017

JCP Editors

Selecting patients with cyclooxygenase-2 (COX-2) expression by immunohistochemistry fails to improve survival outcomes in non-small cell lung cancer (NSCLC), according to research published in the Journal of Clinical...

...

05/15/2017

Journal of Clinical Pathways

Research in Review

PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer

05/12/2017

JCP Editors

New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...

New...

05/12/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse B-Cell Lymphoma

05/12/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...

...

05/12/2017

Journal of Clinical Pathways